Navigation Links
Halpin Foundation and the ASN announce recipient of Halpin Foundation-ASN research grant
Date:10/30/2008

The Halpin Foundation and the American Society of Nephrology (ASN) proudly announce the recipient of the Halpin Foundation-ASN Research Grant for 2008, which was created to provide funding for young faculty to foster evolution to an independent research career by providing transition funding toward successful application for an RO1 grant.

This year's recipient is Elena Torban, PhD. Dr. Torban, Assistant Professor in the Department of Medicine, Division of Nephrology at McGill University, who will focus her research on podocytes, the cells in the glomerulus that are most important for preventing leakage of protein into the urine. Her research is significantly important in understanding the cell and molecular basis for nephrotic syndrome, which is often caused by membranous nephropathy.

The 2007 recipient, Changli Wei, PhD, MD, of the University of Miami Miller School of Medicine, is currently researching the role of TRPC6 in the pathogenesis of membranous nephropathy.

The necessity to gain insight into a kidney disease that causes loss of protein in the urine and a progressive decline in renal function initially partnered The Halpin Foundation with the American Society of Nephrology (ASN) and led to the creation of a fund to promote research relevant to membranous nephropathy in 2004.

The Halpin Foundation dedicated itself to the study of this important kidney disease after the Halpins' 14-year-old son was diagnosed with it in 1989. The foundation is committed to obtaining answers to questions that plague the medical community, including whether there is a hereditary predisposition to the disease. In addition to enabling researchers to better understand this disease, The Halpin Foundation is devoted to raising awareness of the disease in the scientific and lay communities.

"Unfortunately, there are many unanswered questions surrounding membranous nephropathy and nephrotic syndrome, and we are grateful to The Halpin Foundation for helping us fund new investigators to study this disorder," said ASN's President, Peter S. Aronson, MD, FASN.

In a concerted effort to highlight research advances and stimulate investigations regarding membranous nephropathy, ASN will sponsor a Clinical Nephrology Conference devoted to this topic during its annual fall meeting, Renal Week 2008. The session, entitled "Membranous Glomerulonephritis" will take place on Thursday, November 6 from 4:00 p.m. 6:00 p.m. and will feature talks by David J. Salant, MD; Stephan Troyanov, MD; Giuseppe Remuzzi, MD; and Jack F. Wetzels, MD. Joan Halpin, President of the Halpin Foundation, is hopeful this symposium will "attract a diverse audience that will be encouraged to devote time and intellect to the consideration of the pathogenesis and therapy for this disorder."

ASN will also sponsor two Free Communications sessions on nephrotic syndrome during Renal Week. "Genetics of Nephrotic Syndrome and Other Mendelian Syndromes" will take place on Thursday, November 6 from 4:00 p.m. 6:00 p.m., and "New Insights into the Mechanisms of Proteinuria and the Nephrotic Syndrome: Beyond the Slit Diaphragm" will occur on Friday, November 7 from 1:30 p.m. 3:30 p.m..


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
American Society of Nephrology
Source:Eurekalert

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
Breaking Medicine Technology: